Your browser doesn't support javascript.
loading
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol.
Krolewiecki, Alejandro; Enbiale, Wendemagegn; Gandasegui, Javier; van Lieshout, Lisette; Kepha, Stella; Messa Junior, Augusto; Bengtson, Michel; Gelaye, Woyneshet; Escola, Valdemiro; Martinez-Valladares, María; Cambra-Pellejà, María; Algorta, Jaime; Martí-Soler, Helena; Fleitas, Pedro; Ballester, Maria Rosa; Doyle, Stephen R; Williams, Nana Aba; Legarda, Almudena; Mandomando, Inácio; Mwandawiro, Charles; Muñoz, José.
Afiliação
  • Krolewiecki A; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
  • Enbiale W; Instituto de Investigaciones de Enfermedades Tropicales, Universidad Nacional de Salta, Oran, Salta, 4530, Argentina.
  • Gandasegui J; College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
  • van Lieshout L; Department of Dermatology,, Amsterdam Institute for Infection and Immunity, Academic Medical Centre, Amsterdam, The Netherlands.
  • Kepha S; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
  • Messa Junior A; Department of Parasitology, Centre of Infectious Diseases, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
  • Bengtson M; Eastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Gelaye W; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
  • Escola V; Department of Parasitology, Centre of Infectious Diseases, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
  • Martinez-Valladares M; College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
  • Cambra-Pellejà M; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
  • Algorta J; Instituto de Ganadería de Montaña, CSIC-Universidad de León, Grulleros, León, Spain.
  • Martí-Soler H; Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad de León, Campus de Vegazana, León, Spain.
  • Fleitas P; Instituto de Ganadería de Montaña, CSIC-Universidad de León, Grulleros, León, Spain.
  • Ballester MR; Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad de León, Campus de Vegazana, León, Spain.
  • Doyle SR; Liconsa SA, Azuqueca de Henares, Guadalajara, Spain.
  • Williams NA; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
  • Legarda A; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
  • Mandomando I; Instituto de Investigaciones de Enfermedades Tropicales, Universidad Nacional de Salta, Oran, Salta, 4530, Argentina.
  • Mwandawiro C; Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.
  • Muñoz J; Faculty of Health Sciences Blanquerna,, University Ramon Llull, Barcelona, Spain.
Gates Open Res ; 6: 62, 2022.
Article em En | MEDLINE | ID: mdl-36540062
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Gates Open Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Gates Open Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha